Redeye updates its estimates and fair value range following FlexQube’s Q2 report, where sales exceeded our expectations, but the order intake left much to be desired. We do, however, believe that the Q2 order intake is somewhat of a low-water mark as it contained no large orders, and we expect the FlexQube Navigator to be launched in H2, which should generate a new order intake stream.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

© Modular Finance, source Nordic Press Releases